Showing results (171-180 of 256) with videos related to

Sort By:
Pageof 26
Plos One|November 1, 2014
Quantitative and functional characterization of the hyper-conserved protein of Prochlorococcus and marine SynechococcusCaroline E Whidden, Katrina G DeZeeuw, Jackie K Zorz, et al.
Internal Medicine Journal|April 2, 2025
Establishing best practice in the Australian haematology setting for the use of chimeric antigen receptor T-cell therapy for relapsed and refractory lymphomaMichael Dickinson, Nicole O'Leary, Nada Hamad, et al.
Clinical Genetics|March 14, 2018
Hypercalciuria and nephrolithiasis: Expanding the renal phenotype of Donnai-Barrow syndromeF Anglani, L Terrin, M Brugnara, et al.
Journal of Extracellular Vesicles|March 8, 2018
Proteome profiling of extracellular vesicles captured with the affinity peptide Vn96: comparison of Laemmli and TRIzol© protein-extraction methodsAndrew P Joy, D Craig Ayre, Ian C Chute, et al.
Blood|June 19, 2012
CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosisRoss Brown, Karieshma Kabani, James Favaloro, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 3, 2024
Serum Free Light Chain Kinetics Is Predictive of Renal Response in Myeloma Patients With Renal Impairment-An ALLG Trial of Carfilzomib-Dexamethasone Therapy in Frontline and RelapseP Joy Ho, Andrew Spencer, Peter Mollee, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 15, 2025
New Zealand Multiple Myeloma Patients Demonstrate Inferior Outcomes When Compared to Australian Counterparts - A Retrospective Cohort Study from the Myeloma and Related Diseases Registry (MRDR)Jian Li, Yayehirad Melsew, Cameron Wellard, et al.
Frontiers in Oncology|February 5, 2025
Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in AustraliaP Joy Ho, Hang Quach, M Hasib Sidiqi, et al.
Haematologica|October 5, 2023
Single-cell analysis of the CD8<sup>+</sup> T-cell compartment in multiple myeloma reveals disease specific changes are chiefly restricted to a CD69<sup>-</sup> subset suggesting potent cytotoxic effectors exist within the tumor bedJames Favaloro, Christian E Bryant, Edward Abadir, et al.
Leukemia & Lymphoma|February 18, 2014
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocolJay Hocking, Anthony P Schwarer, Robin Gasiorowski, et al.
Pageof 26